Search - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly

Filter your results

60 Results
authFullName_s : François Ducray

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies

Giulia Berzero , Evgenia Karantoni , Caroline Dehais , François Ducray , Laure Thomas et al.
Journal of neurology, neurosurgery, and psychiatry, 2017, 89 (7), pp.789-792. ⟨10.1136/jnnp-2017-316904⟩
Journal articles hal-03049680v1
Image document

SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas

Ahmed Idbaih , François Ducray , Caroline Dehais , Célia Courdy , Catherine Carpentier et al.
PLoS ONE, 2012, 7 (10), pp.e45950. ⟨10.1371/journal.pone.0045950⟩
Journal articles hal-00911465v1
Image document

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH -wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

Louis Garnier , Chrystelle Vidal , Olivier Chinot , Elisabeth Cohen-Jonathan Moyal , Apolline Djelad et al.
Clinical Cancer Research, 2022, 28 (12), pp.2527-2535. ⟨10.1093/oncolo/oyac023⟩
Journal articles hal-03976603v1

Correction: SNP Array Analysis Reveals Novel Genomic Abnormalities Including Copy Neutral Loss of Heterozygosity in Anaplastic Oligodendrogliomas

Ahmed Idbaih , François Ducray , Caroline Dehais , Célia Courdy , Catherine Carpentier et al.
Journal articles hal-03025087v1
Image document

Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome

Romain Appay , Emeline Tabouret , Mehdi Touat , Catherine Carpentier , Carole Colin et al.
Acta Neuropathologica Communications, 2018, 6, pp.89. ⟨10.1186/s40478-018-0594-1⟩
Journal articles hal-01879945v1
Image document

Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model

Edouard Ollier , Pauline Mazzocco , Damien Ricard , Gentian Kaloshi , Ahmed Idbaih et al.
Fundamental & Clinical Pharmacology, 2017, 31 (3), pp.347-358. ⟨10.1111/fcp.12259⟩
Journal articles hal-01623733v1

Characteristics in limbic encephalitis with anti–adenylate kinase 5 autoantibodies

Le-Duy Do , Eve Chanson , Virginie Desestret , Bastien Joubert , François Ducray et al.
Neurology, 2017, 88 (6), pp.514-524. ⟨10.1212/WNL.0000000000003586⟩
Journal articles hal-02095555v1
Image document

Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial

Véronique Quillien , Audrey Lavenu , François Ducray , Marie-Odile Joly , Olivier Chinot et al.
Oncotarget, 2016, 7 (38), pp.61916-61929. ⟨10.18632/oncotarget.11322⟩
Journal articles hal-01358205v1
Image document

RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells

Sébastien Durand , Marion Bruelle , Fleur Bourdelais , Bigitha Bennychen , Juliana Blin-Gonthier et al.
Nature Communications, 2023, 14 (1), pp.356. ⟨10.1038/s41467-023-36037-7⟩
Journal articles hal-04010880v1

Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma

Thiébaud Picart , David Meyronet , Johan Pallud , Chloé Dumot , Philippe Metellus et al.
Journal of Cancer Research and Clinical Oncology, 2021, 147 (6), pp.1843-1856. ⟨10.1007/s00432-020-03474-6⟩
Journal articles hal-03299638v1

Comparison of manual versus automatic delineation of low-grade gliomas based on MR brain scans

Senan Doyle , Benjamin Lemasson , Flor Vasseur , Pierre Bourdillion , François Ducray et al.
Organization for Human Brain Mapping (OHBM) 2014 Annual meeting, Jun 2014, Hambourg, Germany
Conference papers hal-01107700v1

Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort

Tuan Le Van , Thomas Graillon , Julian Jacob , Elodie Vauleon , Loic Feuvret et al.
Journal of Neuro-Oncology, 2021, 153 (1), pp.55-64. ⟨10.1007/s11060-021-03741-7⟩
Journal articles hal-03194557v1

Molecular genetic markers as predictors of response to chemotherapy in gliomas.

Ahmed Idbaih , Antonio Omuro , François Ducray , Khê Hoang-Xuan
Current Opinion in Oncology, 2007, 19 (6), pp.606-11. ⟨10.1097/CCO.0b013e3282f075f3⟩
Journal articles inserm-00310508v1

IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas

Romain Appay , Emeline Tabouret , Nicolas Macagno , Mehdi Touat , Catherine Carpentier et al.
Neuro-Oncology, 2018, 20, pp.716-718. ⟨10.1093/neuonc/noy014⟩
Journal articles hal-01775166v1

Characteristics and management of hydrocephalus in adult patients with cerebellar glioblastoma: lessons from a French nationwide series of 118 cases

Thiébaud Picart , Chloé Dumot , David Meyronet , Johan Pallud , Philippe Metellus et al.
Neurosurgical Review, 2021, ⟨10.1007/s10143-021-01578-2⟩
Journal articles hal-03528344v1
Image document

Input of molecular analysis in medical management of primary brain tumor patients

Ahmed Idbaih , Alberto Duran-Peña , Charlotte Bonnet , François Ducray
Revue Neurologique, 2015, 171 (6–7), pp.457-465. ⟨10.1016/j.neurol.2015.04.002⟩
Journal articles hal-01158523v1

The molecular landscape of glioma in patients with Neurofibromatosis 1

Fulvio d'Angelo , Michele Ceccarelli , Luciano Garofano , Jing Zhang , Véronique Frattini et al.
Nature Medicine, 2019, 25 (1), pp.176-187. ⟨10.1038/s41591-018-0263-8⟩
Journal articles hal-03905472v1

TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.

Ahmed Idbaih , Blandine Boisselier , Yannick Marie , Soufiane El Hallani , Marc Sanson et al.
Cancer Genetics and Cytogenetics, 2007, 177 (2), pp.103-7. ⟨10.1016/j.cancergencyto.2007.06.010⟩
Journal articles istex inserm-00310509v1

Conventional MRI radiomics in patients with suspected early- or pseudo-progression

Alexandre Bani-Sadr , Omer Faruk Eker , Lise-Prune Berner , Roxana Ameli , Marc Hermier et al.
Neuro-Oncology Advances, 2019, 1 (1), ⟨10.1093/noajnl/vdz019⟩
Journal articles hal-03703414v1

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study

Louis Garnier , Chrystelle Vidal , Olivier Chinot , Elisabeth Cohen-Jonathan Moyal , Apolline Djelad et al.
Oncologist, 2022, 27 (5), pp.414-423. ⟨10.1093/oncolo/oyac023⟩
Journal articles hal-03982381v1
Image document

Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults

Thiébaud Picart , Marc Barritault , Delphine Poncet , Lise-Prune Berner , Cristina Izquierdo et al.
Neuro-Oncology Advances, 2021, 3 (1), pp.vdab061. ⟨10.1093/noajnl/vdab061⟩
Journal articles hal-03208021v2
Image document

Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas

Aurélie Kamoun , Ahmed Idbaih , Caroline Dehais , Nabila Elarouci , Catherine Carpentier et al.
Nature Communications, 2016, 7, pp.11263. ⟨10.1038/ncomms11263⟩
Journal articles hal-01320022v1
Image document

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

Emeline Tabouret , Anh Tuan Nguyen , Caroline Dehais , Catherine Carpentier , François Ducray et al.
Acta Neuropathologica, 2016, 132 (4), pp.625-634. ⟨10.1007/s00401-016-1611-8⟩
Journal articles hal-01480146v1

A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549–BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas

David Bret , Valentin Chappuis , Delphine Poncet , François Ducray , Karen Silva et al.
Molecular Diagnosis and Therapy, 2019, 23 (4), pp.537-545. ⟨10.1007/s40291-019-00403-3⟩
Journal articles hal-03811010v1
Image document

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

Alice Bonneville-Levard , Didier Frappaz , Olivier Tredan , Emilie Lavergne , Véronique Corset et al.
Medical Oncology, 2021, 39 (1), pp.4. ⟨10.1007/s12032-021-01536-4⟩
Journal articles hal-03915456v1

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas

Romain Appay , Caroline Dehais , Claude-Alain Maurage , Agusti Alentorn , Catherine Carpentier et al.
Neuro-Oncology, 2019, ⟨10.1093/neuonc/noz124⟩
Journal articles hal-02441014v1
Image document

Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients

Véronique Quillien , Audrey Lavenu , François Ducray , David Meyronet , Olivier Chinot et al.
Cancer Biomarkers, 2017, 20 (4), pp.435-441. ⟨10.3233/CBM-170191⟩
Journal articles hal-01680957v1
Image document

An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas

Julien Laffaire , Anna Luisa Di Stefano , Olivier Chinot , Ahmed Idbaih , Jaime Gallego Perez-Larraya et al.
BioMed Research International , 2014, pp.282815. ⟨10.1155/2014/282815⟩
Journal articles hal-01308273v1
Image document

Characteristics of gliomas in patients with somatic IDH mosaicism

Charlotte Bonnet , Laure Thomas , Dimitri Psimaras , Franck Bielle , Elodie Vauléon et al.
Acta Neuropathologica Communications, 2016, 4, pp.31. ⟨10.1186/s40478-016-0302-y⟩
Journal articles hal-01297851v1

Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas.

Dominique Figarella-Branger , Karima Mokhtari , Caroline Dehais , Catherine Carpentier , Carole Colin et al.
Neuro-Oncology, 2016, 18 (6), pp.888-90. ⟨10.1093/neuonc/now085⟩
Journal articles hal-01576124v1